{"id":1321,"date":"2016-04-27T16:39:17","date_gmt":"2016-04-27T15:39:17","guid":{"rendered":"http:\/\/www.stockportccg.nhs.uk\/practicehub\/?page_id=1321"},"modified":"2022-10-28T14:32:46","modified_gmt":"2022-10-28T13:32:46","slug":"cardiovascular-system","status":"publish","type":"page","link":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/medicines-optimisation-guidance\/cardiovascular-system\/","title":{"rendered":"Cardiovascular System"},"content":{"rendered":"<div class=\"vc_row wpb_row vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-12\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column wpb_content_element \" >\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<p>To visit the main Medicines Optimisation Guidance\u00a0page please click <a href=\"https:\/\/www.stockportccg.nhs.uk\/practicehub\/medicines-optimisation-guidance\/\">here<\/a>.<\/p>\n<p><strong>Heart Failure<\/strong><\/p>\n<ul>\n<li><a href=\"http:\/\/gmmmg.nhs.uk\/docs\/ip\/Sacubitril-Valsartan-info-sheet-for-GPs-final-for-web-2018.pdf\">Information Sheet &#8211; Sacubitril \/ Valsartan<\/a><\/li>\n<\/ul>\n<p><b>Lipid Management<\/b><\/p>\n<ul>\n<li><a href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/18279\/\">National Guidance for Lipid Management for Primary and Secondary Prevention of CVD<\/a><\/li>\n<li><a href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/18282\/\">Inclisiran Dispensing Options Flowchart<\/a><\/li>\n<li><a href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/18285\/\">Inclisiran Patient Leaflet<\/a><\/li>\n<\/ul>\n<p><strong>New Oral Anticoagulants (NOAC<\/strong>)<\/p>\n<p>The new oral Anticoagulants, Rivaroxaban, Dabigatran and Apixaban are now available for initiation in primary care and in limited circumstances for inpatients in secondary care.\u00a0 The drugs are grey listed\u00a0 and must be used within the criteria specified; the grey list can be accessed by clicking <a href=\"https:\/\/www.stockportccg.nhs.uk\/practicehub\/medicines-optimisation\/black-grey-list\/\">here<\/a>.<\/p>\n<p>A range of documents have been developed to support clinicians in considering these medications and help and support is available from the Medicines Management Team, either through the prescribing enquiry e-mail <a href=\"mailto:stoccg.pxenquiries@nhs.net\">stoccg.pxenquiries@nhs.net<\/a>\u00a0or via telephone on 0161 426 9910.<\/p>\n<p>Individual summary of product characteristics can be accessed by searching on the drug name at this website <a href=\"http:\/\/www.medicines.org.uk\/EMC\">http:\/\/www.medicines.org.uk\/EMC<\/a><\/p>\n<p><strong>NOAC Documentation<\/strong><\/p>\n<ul class=\"dlm-downloads\"><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2832\/?tmstv=1776439471\" rel=\"nofollow\">\n        For GMMMG guidance on prescribing NOACs click here    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2834\/?tmstv=1776439471\" rel=\"nofollow\">\n        Referral pathway for NOAC drugs    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-doc\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2836\/?tmstv=1776439471\" rel=\"nofollow\">\n        Record of Inititaion NOAC in AF    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-xls\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2838\/?tmstv=1776439471\" rel=\"nofollow\">\n        Outpatient Flowchart    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-doc\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2842\/?tmstv=1776439471\" rel=\"nofollow\">\n        Patient Counselling checklist    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2844\/?tmstv=1776439471\" rel=\"nofollow\">\n        Leaflet Rivaroxaban for DVT    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2846\/?tmstv=1776439471\" rel=\"nofollow\">\n        Leaflet Dabigatran for AF    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2848\/?tmstv=1776439471\" rel=\"nofollow\">\n        Leaflet Rivaroxaban in AF    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-doc\"\n       title=\"\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2850\/?tmstv=1776439471\" rel=\"nofollow\">\n        Leaflet Apixaban in AF    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2852\/?tmstv=1776439471\" rel=\"nofollow\">\n        Leaflet Rivaroxaban for PE    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-xlsx\"\n       title=\"Version 1\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2854\/?tmstv=1776439471\" rel=\"nofollow\">\n        NOAC transfer for DVT PE    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-xlsx\"\n       title=\"\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/2856\/?tmstv=1776439471\" rel=\"nofollow\">\n        NOAC transfer process for AF patients    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/12275\/?tmstv=1776439471\" rel=\"nofollow\">\n        GMMMG Prescriber Support Tool DOACs in Adults    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/18279\/?tmstv=1776439471\" rel=\"nofollow\">\n        National Guidance for Lipid Management for Primary and Secondary Prevention of CVD    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-docx\"\n       title=\"\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/18282\/?tmstv=1776439471\" rel=\"nofollow\">\n        Inclisiran Dispensing Options Flowchart    <\/a>\n<\/div><\/li><li><div class=\"dl-template\">\n    <a class=\"download-link filetype-icon filetype-pdf\"\n       title=\"\" href=\"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/download\/18285\/?tmstv=1776439471\" rel=\"nofollow\">\n        Inclisiran Patient Leaflet    <\/a>\n<\/div><\/li><\/ul>\n\t\t\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div>\n   ","protected":false},"excerpt":{"rendered":"To visit the main Medicines Optimisation Guidance\u00a0page please click here. Heart Failure Information Sheet - Sacubitril \/ Valsartan Lipid Management National Guidance for Lipid Management for [...]","protected":false},"author":1,"featured_media":0,"parent":69,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-right-sidebar.php","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/pages\/1321"}],"collection":[{"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/comments?post=1321"}],"version-history":[{"count":20,"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/pages\/1321\/revisions"}],"predecessor-version":[{"id":20260,"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/pages\/1321\/revisions\/20260"}],"up":[{"embeddable":true,"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/pages\/69"}],"wp:attachment":[{"href":"https:\/\/www.stockportpracticehub.co.uk\/practicehub\/wp-json\/wp\/v2\/media?parent=1321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}